Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

ACS news: Texas Biotechnology presents synthesis, activity of new VLA-4 antagonist

March 28, 2000

Schering-Plough's new H3 receptor antagonists particularly useful for allergy

March 27, 2000

Ebelsen studied in models of lung injury, lung inflammation

March 23, 2000

Baxter and AlphaOne to codevelop rAAT treatment of hereditary emphysema

March 23, 2000

Shionogi's TxA2 receptor antagonist inactive in model of silica-induced lung fibrosis

March 22, 2000

Drug notification issued for Pulmozyme due to packaging defect

March 22, 2000

Alliance makes progress in phase II/III LiquiVent trial

March 22, 2000

Zambon and Sheffield submit IND to FDA for MSI-ipratropium bromide

March 21, 2000

Subtype-selective PDE4 inhibitors claimed by Pfizer for respiratory and other disorders

March 20, 2000

BOM-1006 selected as a lead benzimidazole for the development of antiallergic agents

March 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...